Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Comparative evaluation of fosinopril and herbal drug Dioscorea bulbifera in patients of diabetic nephropathy.

Singh RG, Rajak M, Ghosh B; Usha, Agrawal A, Dubey GP.

Saudi J Kidney Dis Transpl. 2013 Jul;24(4):737-42.

2.

A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.

Marin R, Ruilope LM, Aljama P, Aranda P, Segura J, Diez J; Investigators of the ESPIRAL Study. Efecto del tratamiento antihipertensivo Sobre la Progresión de la Insuficiencia RenAL en pacientes no diabéticos.

J Hypertens. 2001 Oct;19(10):1871-6.

PMID:
11593109
3.

The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.

Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC.

Diabetes Obes Metab. 2006 May;8(3):342-7.

PMID:
16634995
4.

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.

Keilani T, Schlueter WA, Levin ML, Batlle DC.

Ann Intern Med. 1993 Feb 15;118(4):246-54.

PMID:
8420442
5.

Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.

Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.

Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.

PMID:
15835375
6.

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F.

Diabetes Care. 1998 Apr;21(4):597-603.

PMID:
9571349
8.

Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.

Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.

Afr J Med Med Sci. 2002 Mar;31(1):53-7.

PMID:
12518931
9.

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.

Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ.

Am J Kidney Dis. 1999 Nov;34(5):809-17.

PMID:
10561135
10.

Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.

Toto RD, Tian M, Fakouhi K, Champion A, Bacher P.

J Clin Hypertens (Greenwich). 2008 Oct;10(10):761-9. doi: 10.1111/j.1751-7176.2008.00016.x.

11.
12.

Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy.

Joss N, Ferguson C, Brown C, Deighan CJ, Paterson KR, Boulton-Jones JM.

QJM. 2004 Apr;97(4):219-27.

PMID:
15028852
13.

Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.

Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y.

Diabetologia. 1997 Apr;40(4):405-11.

PMID:
9112017
14.

Risk factors of renal failure progression two years prior to dialysis.

Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A.

Clin Nephrol. 1999 Jun;51(6):355-66.

PMID:
10404696
15.

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

Freedman BI, Wuerth JP, Cartwright K, Bain RP, Dippe S, Hershon K, Mooradian AD, Spinowitz BS.

Control Clin Trials. 1999 Oct;20(5):493-510.

PMID:
10503809
16.

Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.

Cinotti GA, Zucchelli PC; Collaborative Study Group.

Nephrol Dial Transplant. 2001 May;16(5):961-6.

PMID:
11328901
17.

Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.

Khajehdehi P, Pakfetrat M, Javidnia K, Azad F, Malekmakan L, Nasab MH, Dehghanzadeh G.

Scand J Urol Nephrol. 2011 Nov;45(5):365-70. doi: 10.3109/00365599.2011.585622. Epub 2011 May 31.

PMID:
21627399
18.

Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.

Villa E, Rábano A, Ruilope LM, García-Robles R.

Am J Hypertens. 1997 Feb;10(2):202-8.

PMID:
9037329
19.

[Risk and prevention of diabetic nephropathy].

Ravera M, Re M, Deferrari G.

G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:13-9. Italian.

PMID:
17922442
20.

Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.

Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.

Am J Kidney Dis. 2006 Jan;47(1):78-87.

PMID:
16377388

Supplemental Content

Support Center